Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

The present study aimed to investigate the impact of pre-treatment C-reactive protein (CRP) levels on the prediction of prognosis in patients with metastatic renal cell carcinoma (mRCC), who were classified as intermediate-risk patients using the Memorial Sloan Kettering Cancer Center (MSKCC) risk c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: TEISHIMA, JUN, KOBATAKE, KOHEI, HAYASHI, TETSUTARO, SENO, YASUYUKI, IKEDA, KENICHIRO, NAGAMATSU, HIROTAKA, HIEDA, KEISUKE, SHOJI, KOICHI, MIYAMOTO, KATSUTOSHI, INOUE, SHOGO, KOBAYASHI, KANAO, OHARA, SHINYA, KAJIWARA, MITSURU, MATSUBARA, AKIO
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2014
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081304/
https://ncbi.nlm.nih.gov/pubmed/25013512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2207
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars